Trials
Regulations
Contact Us

Welcome to pediculosis.com

Pediculosis.com is the world's only website aimed specifically at researchers, product managers and buyers in the head lice industry.

We provide regularly-updated information on new products, industry changes, regulatory issues, clinical trials and studies to help you identify emerging global trends and business opportunities.

btn-readmore

Industry News

      

Scientific News

newsimg-ind

newsimg-sci

27.08.14 | TyraTech expands retailer base in UK

TyraTech has announced deals with further suppliers in the UK for their VaMousse head lice treatment.

24.07.14 | New Tyratech share & UK distribution deal

Tyratech, inc last week announced a successful share offering along with deals for distribution of its head lice products with UK chemist chains.

05.06.14 | VaMousse now available online across the US

TyraTech Inc recently announced that their VaMOUSSE! range of head lice products are available to purchase online in the United States.

24.01.14 | Tyratech to sell Vamousse through Walmart

Tyratech have recently announced a deal to sell Vamousse, their preventative head lice treatment product, through Walmart in the US.

07.10.13 | Tyratech discussing US distribution of head lice products

Tyratech Inc. is in discussions with distributors to increase the exposure of its head lice treatment range to markets in the US.

27.08.14 | Clinical Trial Roundup

Novel Malathion formation study results

The study Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice by Taro Pharmaceuticals has been updated with results.

The key finding is that the 0.5% Malathion gel eradicated lice in 83% of patricipants, versus 63% for 1% Nix Creme Rinse (n = 47, p = 0.04).

Novel Malathion formation safety results

The study Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice by Taro Pharmaceuticals has been updated with results.

The key finding is that 0.5% malathion gel resulted in clinical evidence of cholinesterase inhibition in two-thirds of participants immediately after treatment, but that this had disappeared after 24 hours. All head lice infection was eradicated after 14 days from treatment (n = 12, no statistical analysis provided).

Pediatric Head Lice Study Product Comparison

The study Pediatric Head Lice Study Product Comparison by Hackensack University Medical Center has been completed.

The study tested the safety and efficacy of 100% Dimethicone Pediculocide in School-Age Children against several standard head lice products (n = 98). Results will be reported when published.

Hatchtech product study recruiting

The study Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation by Hatchtech Pty has been marked as recruiting.

The study expects to test around 50 participants in the coming months.

Hatchtech safety study ongoing

The study Phase 3 Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation by Hatchtech Pty has been marked as ongoing.

The study is currently testing around 380 participants for the tolerability, safety and efficacy of 0.74% Abametapir lotion.

24.07.14 | Review of egg-removal abilities of commercial products

A new study investigates the ability of commercial head lice products to remove eggs from hair.

16.07.14 | Comparison of topical and oral ivermectin

A recent study has found topical ivermectin to have better lice eradication rates than oral ivermectin.

23.06.14 | Further study on herbal shampoos and head lice

A new study further analyses herbal shampoos for their ability to kill head lice.

05.06.14 | FTC fines head lice company for misleading claims

The Federal Trade Commission has fined the manufacturer of Lice Shield $0.5M for misleading advertising claims.

morenews-ind.png morenews-sci.png
  • Pediculosis.com: The world's only specialist website for the head lice industry
  • Company News
  • Scientific News
  • Regulatory News
  • Licecomb Engineering
  • Clinical Trials

Join us on Twitter

pediculosisnews
pediculosisnews Have a look here http://tinyurl.com/o4asgvp for a round up of current clinical trials on #headlice
09:39AM Aug 27
pediculosisnews
pediculosisnews FDA insists lice treatment advertising claims require their approval first. http://www.pediculosis.com/news/scientific-news/regulatory-news/111-best-yet-head-lice-marketing-requires-fda-pre-approval.html
10:42AM Oct 31

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved